FdaApplication

NDA 201152

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBOEHRINGER INGELHEIM PHARMACEUTICALS INC
application_typeNDA
approval_date2011-03-25

Products (2)

ProductActive ingredientStrengthDosage form
VIRAMUNE XRNEVIRAPINE100MGTABLET, EXTENDED RELEASE;ORAL
VIRAMUNE XRNEVIRAPINE400MGTABLET, EXTENDED RELEASE;ORAL

2 products